Grants and Contributions:
Title:
Demonstration of the pharmacokinetics (PKA) and safety profile of cannabidiol (CBD) for canines
Agreement Number:
930685
Agreement Value:
$267,682.00
Agreement Date:
Jun 24, 2019 - Jul 31, 2020
Description:
Demonstration of the pharmacokinetics (PKA) and safety of cannabidiol (CBD) oil in canines using approved, validated study designs and recognized research organizations. End product formulation to be developed with emphasis on palatability, novel combinations for delivery and consistency.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
St Gregor, New Brunswick, CA E3L 5Y9
Reference Number:
172-2019-2020-Q1-930685
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
836799171
Recipient Type:
For-profit organization
Recipient's Legal Name:
Tidal Health Solutions Ltd.
Federal Riding Name:
New Brunswick Southwest
Federal Riding Number:
13008
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
312310